These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2498958)

  • 21. Effects of lithium carbonate on sleep.
    Chernik DA; Cochrane C; Mendels J
    J Psychiatr Res; 1974 May; 10(2):133-46. PubMed ID: 4443951
    [No Abstract]   [Full Text] [Related]  

  • 22. Longitudinal study of the effects of lithium carbonate on the sleep of hospitalized depressed patients.
    Chernik DA; Mendels J
    Biol Psychiatry; 1974 Oct; 9(2):117-23. PubMed ID: 4371883
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H; Burki HR
    Neuropsychobiology; 1987; 17(4):206-12. PubMed ID: 2964564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep suppressant action of quipazine: relation to central serotonergic stimulation.
    Fornal C; Radulovacki M
    Pharmacol Biochem Behav; 1981 Dec; 15(6):937-44. PubMed ID: 7323120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of selective activation of the 5-HT1B receptor with CP-94,253 on sleep and wakefulness in the rat.
    Monti JM; Monti D; Jantos H; Ponzoni A
    Neuropharmacology; 1995 Dec; 34(12):1647-51. PubMed ID: 8788962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pharmacologic treatments on the sleep of depressed patients.
    Sharpley AL; Cowen PJ
    Biol Psychiatry; 1995 Jan; 37(2):85-98. PubMed ID: 7718684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ritanserin-induced changes in sleep-waking phases in rats.
    Kirov R; Moyanova S
    Acta Physiol Pharmacol Bulg; 1995; 21(4):87-92. PubMed ID: 8830880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. meta-Chlorophenylpiperazine decreases slow-wave sleep in humans.
    Katsuda Y; Walsh AE; Ware CJ; Cowen PJ; Sharpley AL
    Biol Psychiatry; 1993 Jan; 33(1):49-51. PubMed ID: 8420595
    [No Abstract]   [Full Text] [Related]  

  • 30. Lesion of descending 5-HT pathways increases zimeldine-induced waking in rats.
    Bjørkum AA; Neckelmann D; Bjorvatn B; Ursin R
    Physiol Behav; 1995 May; 57(5):959-66. PubMed ID: 7610150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra.
    Dijk DJ; Beersma DG; Daan S; van den Hoofdakker RH
    Eur J Pharmacol; 1989 Nov; 171(2-3):207-18. PubMed ID: 2576000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power.
    Brandenberger G; Luthringer R; Muller G; Gronfier C; Schaltenbrand N; Macher JP; Muzet A; Follenius M
    J Endocrinol Invest; 1996 Sep; 19(8):556-62. PubMed ID: 8905480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers.
    Wilson SJ; Bailey JE; Alford C; Nutt DJ
    J Psychopharmacol; 2000; 14(4):378-86. PubMed ID: 11198056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RP 62203, a 5-hydroxytryptamine2 antagonist, enhances deep NREM sleep in rats.
    Stutzmann JM; Eon B; Lucas M; Blanchard JC; Laduron PM
    Sleep; 1992 Apr; 15(2):119-24. PubMed ID: 1579785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma catecholamines and selective slow wave sleep deprivation.
    Tiemeier H; Pelzer E; Jönck L; Möller HJ; Rao ML
    Neuropsychobiology; 2002; 45(2):81-6. PubMed ID: 11893864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin control of sleep-wake behavior.
    Monti JM
    Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the rat.
    Dugovic C; Leysen JE; Janssen PF; Wauquier A
    Pharmacol Biochem Behav; 1989 Nov; 34(3):533-7. PubMed ID: 2516324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats.
    Bjorvatn B; Fagerland S; Eid T; Ursin R
    Brain Res; 1997 Oct; 770(1-2):81-8. PubMed ID: 9372206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sleep in Huntington chorea: its modification following lithium carbonate and lithium carbonate-haloperidol therapy].
    Puca F; Specchio LM; Genco S; Internò S; Castriotta R
    Riv Neurol; 1978; 48(6):708-16. PubMed ID: 154167
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of a GABA(B) receptor antagonist on the sleep-waking cycle in the rat.
    Gauthier P; Arnaud C; Gandolfo G; Gottesmann C
    Brain Res; 1997 Oct; 773(1-2):8-14. PubMed ID: 9409699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.